Researchers to create the first systematic surveillance program of men with prostate cancer to look for biological clues to help determine when to wait and when to treat the disease.
Ads by Google
Prostate Cancer Treatment and Symptoms
Therapies under development for prostate cancer treatment by inhibiting the ability of insulin-like growth factor (IGF-1) to activate its target receptor could have unexpected results especially if a major tumor suppressor gene - p53 - is already compromised.
Men whose prostate cancer screenings show high grade prostatic intraepithelial neoplasia (HG-PIN) may find themselves in limbo, 'stuck' between diagnoses - they are told prostate cancer has not yet developed, but it might, and they are advised to undergo repeated needle biopsies as a precaution.
Prostate tumors grew more quickly in mice who exercised than in those who did not, leading to speculation that exercise may increase blood flow to tumors.
Many men who receive microwave therapy for enlarged prostates experience significant surges in blood pressure that could raise their risk of a heart attack or stroke.
Changes in Medicare reimbursement policy might have prompted more beneficiaries to undergo surgical castration to treat prostate cancer rather than a less invasive alternative.
Prostate size, other neglected factors influence satisfaction with treatment outcomes.
When a couple is dealing with prostate cancer, a partner's psychological distress might drag down the well-being of either person.
Prostate cancer patients are suggested not to treat the disease immediately after detecting it, because there are good chances that the disease won't get worse.
Henry Ford Hospital is embarking on an expanded major clinical trial involving the use of gene therapy in combination with radiation therapy, to determine if the combined treatment for prostate cancer is more effective than radiation therapy alone for patients with intermediate risk prostate cancer.
Patients who undergo complete prostate removal are less likely to experience urinary incontinence or other complications if the operation is done by an experienced surgeon.
Is it safe to wait to make a decision about having prostate cancer surgery, even after you've waited and waited for all the doctor appointments and test results? Or will the additional delay reduce your chances of being cured? Reassuring research says that men can take the time they need to make their decisions, reports the February 2008 issue of Harvard Men's Health Watch.
Validated nomogram tool can identify normal PSA level patients at risk for aggressive prostate cancer and has been shown to perform better than conventional screening.
Researchers analyzing prostate tumors have identified differences in gene expression between African-American and European-American men.
Although androgen suppression therapy has been shown to increase the risk of cardiovascular events, the survival benefit it may offer to certain patients has been unclear.
Men with enlarged prostates who took a combination of AVODART, tamsulosin experienced significantly greater improvement in urinary symptoms than men prescribed either medication alone.
In experiments with mice, researchers have found that the body's immune system can use a surprisingly common molecule to recognize prostate tumors. The molecule comes from a protein found in all cells of the body; however, immune cells appear to respond to it only when it is present on the surface of cells within a tumor.
Gold Supplement is focused on a series of 12 peer-reviewed studies on the use of focal therapy in the treatment of prostate cancer.
A signaling protein that is key to prostate cancer cell growth is turned on in nearly all recurrent prostate cancers that are resistant to hormone therapy.
Testing rates are increasing despite a lack of evidence for reduced prostate cancer mortality.
The death of Dan Fogelberg puts prostate cancer and treatment options again in focus of public attention.
A new clinic in Cancun, Mexico will offer treatment of localized prostate cancer with HIFU, an ultrasound therapy. This is the second facility in Mexico to offer this therapy; HIFU is also available at Hospital San Javier located in Puerto Vallarta.
Men with early prostate cancer received therapies that might not be appropriate, based on pre-existing problems with urinary, bowel or sexual function.
Prostate cancer screening occurs in many countries ahead of evidence from ongoing trials.